FindTrial
Sign In

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06830590
Acronym
BrCa
Enrollment
300
Registered
2025-02-17
Start date
2016-02-01
Completion date
2025-12-31
Last updated
2025-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Molecular Pathway Deregulation, Treatment

Keywords

Breast cancer, Molecular characterisation

Brief summary

This study is looking at the biological characteristics of early operable primary breast cancer in Pakistani Population by using IHC

Interventions

PROCEDUREMolecular characterisation

All patients treated by surgery were included without any neoadjuvant therapy

Sponsors

Liaquat University of Medical & Health Sciences
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Women with confirmed diagnosis of breast cancer without history of taking neoadjuvant therapy Good quality tumour samples available for IHC

Exclusion criteria

* patients received pre-operative chemotherapy or radiotherapy

Design outcomes

Primary

MeasureTime frame
Breast cancer specific survival in correlation with molecular pattern10 years

Countries

Pakistan

Contacts

Primary ContactBinafsha Manzoor M Syed, MBBS, PhD
Binafsha.syed@lumhs.edu.pk+923332749201

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026